Schülke & Mayr GmbH and AM Instruments today announce the acquisition of AM Instruments, one of Italy's leading specialists in contamination control and cleanroom solutions for the Life Sciences industry. The acquisition represents another important milestone in schülke's Life Science growth strategy. AM Instruments complements schülke's existing portfolio with a broad range of cleanroom consumables. Its strong technical capabilities, GMP-oriented culture, and highly customer-centric approach allowed AM Instruments to build an exceptional reputation across the pharmaceutical industry over the last thirty years. Together, our future organization will be uniquely positioned to support pharmaceutical and biotechnology customers across the entire contamination control value chain. This partnership is founded on a common vision, a similar entrepreneurial mindset, and a deep commitment to quality, innovation, customer focus, and long-term value creation. To ensure continuity for customers, partners and employees, Cinzia Pagani and Roberto Fossati will continue to support the company, working closely with the new organization during the next phase of its development.

Merck, ein führendes Wissenschafts- und Technologieunternehmen, hat an seiner Konzernzentrale in Darmstadt ein neues BioReliance®-Prüfzentrum für 25 Millionen Euro eröffnet. Mit der Investition stärkt Merck nicht nur seinen Hauptsitz, sondern macht Darmstadt zu einem Schlüsselstandort in seinem weltweiten Netzwerk von Prüfzentren für die Arzneimittelentwicklung und -freigabe.

Du arbeitest im Reinraum? Dann lies die folgenden 7 Überlebensregeln (einige Szenen kommen Dir garantiert bekannt vor)